Sign up
Log in
12 Health Care Stocks Moving In Tuesday's Intraday Session
Share
Listen to the news

Gainers

  • Neurogene (NASDAQ:NGNE) shares increased by 32.3% to $19.77 during Tuesday's regular session. The market value of their outstanding shares is at $213.2 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 32.16% to $0.4. The company's market cap stands at $4.7 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 27.66% to $1.16. The market value of their outstanding shares is at $2.4 million.
  • Vivos Therapeutics (NASDAQ:VVOS) shares increased by 25.47% to $3.96. The company's market cap stands at $18.6 million.
  • Soligenix (NASDAQ:SNGX) stock increased by 18.32% to $1.55. The market value of their outstanding shares is at $4.2 million.
  • Mustang Bio (NASDAQ:MBIO) shares moved upwards by 18.22% to $1.13. The company's market cap stands at $4.1 million.

Losers

  • Oragenics (AMEX:OGEN) stock fell 57.3% to $1.63 during Tuesday's regular session. The company's market cap stands at $2.7 million.
  • Geovax Labs (NASDAQ:GOVX) shares decreased by 46.0% to $0.47. The market value of their outstanding shares is at $13.7 million.
  • Cellectar Biosciences (NASDAQ:CLRB) stock fell 31.23% to $4.89. The market value of their outstanding shares is at $12.8 million.
  • Artelo Biosciences (NASDAQ:ARTL) stock decreased by 28.33% to $9.51. The company's market cap stands at $7.2 million.
  • Exicure (NASDAQ:XCUR) shares decreased by 14.64% to $6.01. The market value of their outstanding shares is at $44.4 million. The company's, Q1 earnings came out 2 days ago.
  • Enhabit (NYSE:EHAB) shares fell 14.16% to $8.28. The company's market cap stands at $488.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.